156 related articles for article (PubMed ID: 15163359)
1. Transgenic mouse models of Alzheimer's disease: how useful have they been for therapeutic development?
Duff K; Suleman F
Brief Funct Genomic Proteomic; 2004 Apr; 3(1):47-59. PubMed ID: 15163359
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mouse models of Alzheimer's disease.
Hock BJ; Lamb BT
Trends Genet; 2001 Oct; 17(10):S7-12. PubMed ID: 11585670
[TBL] [Abstract][Full Text] [Related]
3. Biological transgenic mouse models of Alzheimer's disease.
Crews L; Rockenstein E; Masliah E
Handb Clin Neurol; 2008; 89():291-301. PubMed ID: 18631753
[No Abstract] [Full Text] [Related]
4. Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.
Wang QH; Wang YR; Zhang T; Jiao SS; Liu YH; Zeng F; Li J; Yao XQ; Zhou HD; Zhou XF; Wang YJ
J Neurochem; 2016 Jul; 138(1):163-73. PubMed ID: 26991827
[TBL] [Abstract][Full Text] [Related]
5. Generation of App knock-in mice reveals deletion mutations protective against Alzheimer's disease-like pathology.
Nagata K; Takahashi M; Matsuba Y; Okuyama-Uchimura F; Sato K; Hashimoto S; Saito T; Saido TC
Nat Commun; 2018 May; 9(1):1800. PubMed ID: 29728560
[TBL] [Abstract][Full Text] [Related]
6. Mouse models of Alzheimer's disease: the long and filamentous road.
Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D
Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012
[TBL] [Abstract][Full Text] [Related]
7. Making models for Alzheimer's disease.
Lamb BT
Nat Genet; 1995 Jan; 9(1):4-6. PubMed ID: 7704022
[No Abstract] [Full Text] [Related]
8. Characterization of an 'Amyloid Only' Transgenic (B6C3-Tg(APPswe,PSEN1dE9)85Dbo/Mmjax) Mouse Model of Alzheimer's Disease.
Finnie GS; Gunnarsson R; Manavis J; Blumbergs PC; Mander KA; Edwards S; Van den Heuvel C; Finnie JW
J Comp Pathol; 2017 May; 156(4):389-399. PubMed ID: 28431735
[TBL] [Abstract][Full Text] [Related]
9. Images in neuroscience. Alzheimer's disease: from genes to pathogenesis.
Selkoe DJ
Am J Psychiatry; 1997 Sep; 154(9):1198. PubMed ID: 9286176
[No Abstract] [Full Text] [Related]
10. The exosome of adipose-derived stem cells reduces β-amyloid pathology and apoptosis of neuronal cells derived from the transgenic mouse model of Alzheimer's disease.
Lee M; Ban JJ; Yang S; Im W; Kim M
Brain Res; 2018 Jul; 1691():87-93. PubMed ID: 29625119
[TBL] [Abstract][Full Text] [Related]
11. Intensive 'Brain Training' Intervention Fails to Reduce Amyloid Pathologies or Cognitive Deficits in Transgenic Mouse Models of Alzheimer's Disease.
Anderson M; Xu F; Ou-Yang MH; Davis J; Van Nostrand WE; Robinson JK
J Alzheimers Dis; 2017; 55(3):1109-1121. PubMed ID: 27767989
[TBL] [Abstract][Full Text] [Related]
12. Time sequence of oxidative stress in the brain from transgenic mouse models of Alzheimer's disease related to the amyloid-β cascade.
Belkacemi A; Ramassamy C
Free Radic Biol Med; 2012 Feb; 52(3):593-600. PubMed ID: 22172527
[TBL] [Abstract][Full Text] [Related]
13. Cellular and molecular biology of Alzheimer's disease and animal models.
Price DL; Sisodia SS
Annu Rev Med; 1994; 45():435-46. PubMed ID: 8198393
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mouse models of Alzheimer's disease: phenotype and application.
Higgins GA; Jacobsen H
Behav Pharmacol; 2003 Sep; 14(5-6):419-38. PubMed ID: 14501255
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
18. Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease.
Allué JA; Sarasa L; Izco M; Pérez-Grijalba V; Fandos N; Pascual-Lucas M; Ogueta S; Pesini P; Sarasa M
J Alzheimers Dis; 2016 May; 53(3):773-85. PubMed ID: 27258422
[TBL] [Abstract][Full Text] [Related]
19. Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease.
van Tijn P; Dennissen FJ; Gentier RJ; Hobo B; Hermes D; Steinbusch HW; Van Leeuwen FW; Fischer DF
Neurochem Int; 2012 Oct; 61(5):739-48. PubMed ID: 22797007
[TBL] [Abstract][Full Text] [Related]
20. Mouse models reveal why Alzheimer's treatment fails.
Niemeyer JE
Lab Anim (NY); 2016 Apr; 45(4):125. PubMed ID: 27003340
[No Abstract] [Full Text] [Related]
[Next] [New Search]
